Patients with high FLOT1 better simulation of tumor invasion survival (P = 0.003; hazard ratio (HR) (95% confidence interval (CI)) = 2.63 (1.40–4.93)) and disease-free survival (P = 0.003; HR (95% CI) = 2.18 (1.29–3.67)) compared to patients with low FLOT1 expression (Figure 1E). This evidence concerns the gene FLOT1 and neoplasm.